All stock lists
Unlock the score
Cel Sci Corp (New York Stock Exchange Arca:CVM)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.59-0.05 (-3.05%)
Market cap
$28.0M
Insider Score
Health Score
Analyst consensus
Listed since
Dec 8, 1983
Website
Insider Score
/ 100
CVM Insider Score
CEL SCI CORP has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
CVM Stock Insider Trading Activity
CVM stock’s insider trading shows 3 purchases for an estimated $617.00K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days1 qualifying buy1 insider$138.00K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| TALOR EYAL Other | Award | 1,165 | $2.06 | $2.40K | 12.5% | 10,483 | Sep 30, 2026 | — | Form 4 |
| PRICHEP PATRICIA B CFO | Award | 2,082 | $2.06 | $4.29K | 11.9% | 19,571 | Sep 30, 2026 | — | Form 4 |
| KERSTEN GEERT R CEO | Award | 2,621 | $2.06 | $5.40K | 0.8% | 318,763 | Sep 30, 2026 | — | Form 4 |
| KERSTEN GEERT R CEO | Buy | 100,000 | $1.38 | $138.00K | 46.3% | 316,142 | Aug 25, 2026 | BCEO BuyDilution | Form 4 |
| KERSTEN GEERT R CEO | Award | 5,192 | $1.04 | $5.40K | 2.5% | 216,142 | Jun 30, 2026 | — | Form 4 |
| PRICHEP PATRICIA B CFO | Award | 4,125 | $1.04 | $4.29K | 30.9% | 17,489 | Jun 30, 2026 | — | Form 4 |
| TALOR EYAL Other | Award | 2,307 | $1.04 | $2.40K | 32.9% | 9,318 | Jun 30, 2026 | — | Form 4 |
| KERSTEN GEERT R CEO | Buy | 300,000 | $1.20 | $360.00K | 2598% | 311,547 | May 14, 2026 | A+Stake DoublerCEO BuyDilution | Form 4 |
| KERSTEN GEERT R CEO | Buy | 100,000 | $1.19 | $119.00K | 81.6% | 222,497 | May 13, 2026 | ACEO BuyDilution | Form 4 |
| PRICHEP PATRICIA B CFO | Award | 1,336 | $3.21 | $4.29K | 11.1% | 13,364 | Mar 31, 2026 | — | Form 4 |
| KERSTEN GEERT R CEO | Award | 1,682 | $3.21 | $5.40K | 1.4% | 122,497 | Mar 31, 2026 | — | Form 4 |
| TALOR EYAL Other | Award | 747 | $3.21 | $2.40K | 11.9% | 7,011 | Mar 31, 2026 | — | Form 4 |
| KERSTEN GEERT R CEO | Buy | 38,023 | $5.26 | $200.00K | 45.9% | 120,815 | Jan 22, 2026 | ACEO BuyDilution | Form 4 |
| KERSTEN GEERT R CEO | Award | 998 | $5.26 | $5.25K | 1.2% | 82,792 | Dec 31, 2025 | — | Form 4 |
| TALOR EYAL Other | Award | 456 | $5.26 | $2.40K | 7.9% | 6,264 | Dec 31, 2025 | — | Form 4 |
| PRICHEP PATRICIA B CFO | Award | 815 | $5.26 | $4.29K | 7.3% | 12,028 | Dec 31, 2025 | — | Form 4 |
| KERSTEN GEERT R CEO | Buy | 8,389 | $5.96 | $50.00K | 11.4% | 81,794 | Dec 4, 2025 | BFirst BuyCEO BuyDilution | Form 4 |
| TALOR EYAL Other | Award | 260 | $9.20 | $2.39K | 4.7% | 5,808 | Sep 30, 2025 | — | Form 4 |
| PRICHEP PATRICIA B CFO | Award | 466 | $9.20 | $4.29K | 4.3% | 11,213 | Sep 30, 2025 | — | Form 4 |
| KERSTEN GEERT R CEO | Award | 570 | $9.20 | $5.24K | 0.8% | 73,405 | Sep 30, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Award (A) — Grant or award from the company, not a purchase
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.